STOCK TITAN

Xtant Medical Holdings Inc - XTNT STOCK NEWS

Welcome to our dedicated news page for Xtant Medical Holdings (Ticker: XTNT), a resource for investors and traders seeking the latest updates and insights on Xtant Medical Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Xtant Medical Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Xtant Medical Holdings's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.2%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.89%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.84%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.25%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.11%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.46%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
Xtant Medical Holdings Inc

NYSE:XTNT

XTNT Rankings

XTNT Stock Data

109.02M
39.72M
8.16%
69.27%
0.22%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Belgrade

About XTNT

xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.